ELAAVATE Trademark

Trademark Overview

On Thursday, April 8, 2021, a trademark application was filed for ELAAVATE with the United States Patent and Trademark Office. The USPTO has given the ELAAVATE trademark a serial number of 90632317. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 1, 2024. This trademark is owned by REGENXBIO Inc.. The ELAAVATE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others
elaavate

General Information

Serial Number90632317
Word MarkELAAVATE
Filing DateThursday, April 8, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 4, 2022

Trademark Statements

Pseudo MarkELEVATE
Goods and ServicesProviding medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 16, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameREGENXBIO Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameREGENXBIO Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Monday, April 12, 2021NEW APPLICATION ENTERED
Monday, June 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 27, 2021ASSIGNED TO EXAMINER
Thursday, December 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, August 28, 2022SOU TEAS EXTENSION RECEIVED
Sunday, August 28, 2022SOU EXTENSION 1 FILED
Sunday, August 28, 2022SOU EXTENSION 1 GRANTED
Saturday, September 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 23, 2023SOU EXTENSION 2 FILED
Thursday, February 23, 2023SOU EXTENSION 2 GRANTED
Saturday, February 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, June 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 14, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, April 1, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, December 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 14, 2023SOU EXTENSION 3 FILED
Monday, August 14, 2023SOU EXTENSION 3 GRANTED

Related Keywords

elaavate trials clinical research medical scientific conducting others namely field information